iZafe Group Past Earnings Performance
Past criteria checks 0/6
iZafe Group's earnings have been declining at an average annual rate of -10.1%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been declining at an average rate of 46.3% per year.
Key information
-10.1%
Earnings growth rate
31.5%
EPS growth rate
| Healthcare Services Industry Growth | 7.9% |
| Revenue growth rate | -46.3% |
| Return on equity | -204.6% |
| Net Margin | -508.7% |
| Next Earnings Update | 14 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How iZafe Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 6 | -32 | 16 | 0 |
| 30 Jun 24 | 5 | -32 | 15 | 0 |
| 31 Mar 24 | 5 | -33 | 15 | 0 |
| 31 Dec 23 | 2 | -32 | 14 | 0 |
| 30 Sep 23 | 1 | -20 | 15 | 0 |
| 30 Jun 23 | 1 | -21 | 16 | 0 |
| 31 Mar 23 | 1 | -22 | 16 | 0 |
| 31 Dec 22 | 1 | -24 | 19 | 0 |
| 30 Sep 22 | 1 | -31 | 25 | 0 |
| 30 Jun 22 | 1 | -31 | 25 | 0 |
| 31 Mar 22 | 1 | -34 | 27 | 0 |
| 31 Dec 21 | 0 | -36 | 27 | 0 |
| 30 Sep 21 | 1 | -32 | 24 | 0 |
| 30 Jun 21 | 1 | -19 | 26 | 0 |
| 31 Mar 21 | 5 | -16 | 27 | 0 |
| 31 Dec 20 | 9 | -13 | 29 | 0 |
| 30 Sep 20 | 13 | -11 | 31 | 0 |
| 30 Jun 20 | 16 | -22 | 31 | 0 |
| 31 Mar 20 | 15 | -23 | 18 | 0 |
| 31 Dec 19 | 14 | -23 | 31 | 0 |
| 30 Sep 19 | 15 | -18 | 25 | 0 |
| 30 Jun 19 | 14 | -16 | 22 | 0 |
| 31 Mar 19 | 11 | -14 | 10 | 0 |
| 31 Dec 18 | 8 | -11 | 7 | 0 |
| 30 Sep 18 | 3 | -11 | 4 | 0 |
| 30 Jun 18 | 1 | -10 | 2 | 0 |
| 31 Mar 18 | 1 | -7 | 1 | 0 |
| 31 Dec 17 | 1 | -4 | 1 | 0 |
| 30 Sep 17 | 0 | -2 | 1 | 0 |
| 30 Jun 17 | 0 | -2 | 0 | 0 |
| 31 Mar 17 | 0 | -6 | 0 | 0 |
| 31 Dec 16 | 0 | -6 | 0 | 0 |
| 30 Sep 16 | 0 | -7 | 0 | 0 |
| 30 Jun 16 | 0 | -7 | 0 | 0 |
| 31 Mar 16 | 0 | -3 | 0 | 0 |
| 31 Dec 15 | 0 | -3 | 1 | 0 |
| 30 Sep 15 | 0 | -3 | 2 | 0 |
| 30 Jun 15 | 0 | -3 | 1 | 0 |
| 31 Mar 15 | 0 | -3 | 1 | 0 |
| 31 Dec 14 | 0 | -3 | 1 | 0 |
| 30 Sep 14 | 0 | -7 | 0 | 0 |
| 30 Jun 14 | 0 | -7 | 1 | 0 |
| 31 Mar 14 | 0 | -4 | 0 | 0 |
| 31 Dec 13 | 0 | -7 | 0 | 0 |
Quality Earnings: M02 is currently unprofitable.
Growing Profit Margin: M02 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M02 is unprofitable, and losses have increased over the past 5 years at a rate of 10.1% per year.
Accelerating Growth: Unable to compare M02's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: M02 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: M02 has a negative Return on Equity (-204.59%), as it is currently unprofitable.